Effect of empagliflozin on liver fibrosis and steatosis in patients with type 2 diabetes and non-alcoholic fatty liver disease: a randomized clinical trial.

ABSTRACT:

SUBMITTER: Erfanifar A 

PROVIDER: S-EPMC12664258 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature